Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFβ/MYH11 rearrangement

Haematologica

Volumn 85, Issue 7, 2000, Pages 699-703

  Martin, G ^a   Barragan, E ^a   Bolufer, P ^a   Chillon, C ^a   Garcia Sanz, R ^a   Gomez, T ^a   Brunet, S ^a   Gonzalez, M ^a   Sanz, M A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Acute myeloid leukemia; CBF MYH11; MRD

Indexed keywords

ANTHRACYCLINE; BINDING PROTEIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; IDARUBICIN; MYOSIN HEAVY CHAIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CYTOGENETICS; FEMALE; FOLLOW UP; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MINIMAL RESIDUAL DISEASE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 16; DISEASE-FREE SURVIVAL; FEMALE; GENE REARRANGEMENT; HUMANS; KINETICS; LEUKEMIA, MYELOID; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; ONCOGENE PROTEINS, FUSION; PROGNOSIS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033854189     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia
2. Chromosome 16 abnormalities associated with myeloid malignancies
3. Detection and quantitation of the CBFβ/MYH11 transcripts associated with the inv(16)in presentation and follow-up samples from patients with AML
4. Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) and t(16;16) has a favorable prognosis
5. Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literature
6. On behalf of the Medical Research Council Adult and Children's Leukaemia Working Parties. The importance of diagnostic cytogenetics on outcome in AML analysis of 1612 patients entered into the MRC AML 10 Trial
7. Fusion between transcription factor CBFβ/PEBP2b and a myosin heavy chain in acute myeloid leukemia
8. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia
9. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification
10. Detection of fusion transcripts generated by inversion 16 chromosome in acute myelogenous leukemia
11. RT-PCR monitoring of CBFβMYH11 in patients with AML and a chromosomal inv(16): Variable behaviour of the chimeric mRNA during treatment
12. Detection of the chromosome 16 CBFβ-MYH11 fusion transcript in myelomonocytic leukemias
13. Detection of CBFβ/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission
14. Prognosis value of residual disease monitoring by polymerase chain reaction in patients with CBFβ/MYH11-positive acute myeloblastic leukemia
15. Defining the 'absence' of the CBFβ-MYH 11 fusion transcript in patients with acute myeloid leukemia and inversion of chromosome 16 to predict long-term complete remission: A call for definitions
16. Competitive CBFβ/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): A pilot study
17. Detection of CBFβ/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation
18. Prospective monitoring of minimal residual disease by polymerase chain reaction in patients with acute myeloid leukemia expressing CBFβ/MYH11 fusion transcript
19. BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remission
20. Single-step method of RNA isolation byacid guanidium thiocyanate-phenol-chloroform extraction
21. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia
22. ISCN: An international system for human cytogenetic nomenclature
23. Non-parametric estimations from incomplete observations
24. Evaluation of survival data and two new rank order statistic arising in its consideration
25. Curative impact of intensification with high dose cytarabine (DAC) in acute myeloid leukemia (AML)varies by cytogenetic group
26. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22)
27. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): Results from Cancer and Leukemia Group B
28. Comparison of two reverse transcription-polymerase chain reaction methods for detection of AML1/ETO rearrangement in the M2 subtype of acute myeloid leukaemia
29. Disappearance of AML1-METG8 (ETO) fusion transcript in acute myeloid leukemia patients with t(8;21)in long term remission
30. Molecular monitoring of the myl/retinoic acid receptor α fusion gene in acute promyelocytic leukemia by polymerase chain reaction
31. Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy
32. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia patients